Search bioRxiv⌕ Search

Biology subjects

Lodge, R.

Publications and source records attributed to Lodge, R..

2 recordsLinked to original sources

Impact of HIV-1 infection on the microglia transcriptome: induction of microRNA-23b leads to G3BP2-mediated stress granules assembly disruption

Microglia act as HIV reservoirs in the brain and contribute to the development of HIV-associated neurocognitive disorders despite antiretroviral therapy. We examined the transcriptome of primary microglia infected ex vivo with HIV-1. Analyses reveal a significant modulation of DNA damage/cell cycle-, cellular stress- and non-membrane bounded organelle assembly-related gene expression, and a broad effect on the microRNA profile. MicroRNA-23b is identified among upregulated microRNAs in HIV-1-infected microglia, and downregulated g3bp2 mRNA, validated as its target. G3BP2 is a core component of stress granules (SGs), which serve as antiviral and proinflammatory platforms. MicroRNA-23b mimics reduced both G3BP2 expression and SG assembly in stress-induced monocyte-derived microglial cells (MDMi), and few SGs aggregate in infected MDMi. Inhibition of MicroRNA-23b partially re-established SG formation and reduced HIV-1 replication. Thus, microRNA-23b induction contributes to HIV-1 strategies aimed at counteracting SG assembly in infected microglia, a host response that restricts HIV-1 replication and ensuing neuropathogenesis.

microbiology↗

THERAPEUTIC EFFECTS OF HYPOXIC AND PRO-INFLAMMATORY PRIMING OF MESENCHYMAL STEM CELL-DERIVED EXTRACELLULAR VESICLES IN INFLAMMATORY ARTHRITIS

Novel biological therapies have revolutionised the management of Rheumatoid Arthritis (RA) but no cure currently exists. Mesenchymal stem cells (MSCs) immunomodulate inflammatory responses through paracrine signalling, including via secretion of extracellular vesicles (EVs) in the cell secretome. We evaluated the therapeutic potential of MSCs-derived small EVs in an antigen-induced model of arthritis (AIA). EVs isolated from MSCs cultured normoxically (21% O2, 5% CO2), hypoxically (2% O2, 5% CO2) or with a pro-inflammatory cytokine cocktail were applied into the AIA model. Disease pathology was assessed post-arthritis induction through swelling and histopathological analysis of synovial joint structure. Activated CD4+ T cells from healthy mice were cultured with EVs or MSCs to assess deactivation capabilities prior to application of standard EVs in vivo to assess T cell polarisation within the immune response to AIA. All EVs treatments reduced knee-joint swelling whilst only normoxic and pro-inflammatory primed EVs improved histopathological outcomes. In vitro culture with EVs did not achieve T cell deactivation. Polarisation towards CD4+ helper cells expressing IL17a (Th17) was reduced when normoxic and hypoxic EV treatments were applied in vitro. Normoxic EVs applied into the AIA model reduced Th17 polarisation and improved Th17:Treg homeostatic balance. Priming of MSCs in EV production can be applied to alter the therapeutic efficacy however normoxic EVs present the optimal strategy for broad therapeutic benefit. The varied outcomes observed in MSCs priming may promote EVs optimised for therapies targeted for specific therapeutic priorities. EVs present an effective novel technology with potential for cell-free therapeutic translation.

immunology↗